These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Nanomedicine-mediated drug delivery for potential treatment of inflammatory bowel disease: a narrative review. Ardekani ZM; Lorenzo-Leal AL; Bach H Nanomedicine (Lond); 2024 Jan; 19(2):163-179. PubMed ID: 38284393 [No Abstract] [Full Text] [Related]
6. Personalised therapy in inflammatory bowel disease. Calderón P; Núñez P; Nos P; Quera R Gastroenterol Hepatol; 2024; 47(7):763-770. PubMed ID: 38101615 [TBL] [Abstract][Full Text] [Related]
7. Cytokines of the interleukin-6 family as emerging targets in inflammatory bowel disease. Garbers C; Lokau J Expert Opin Ther Targets; 2024; 28(1-2):57-65. PubMed ID: 38217849 [TBL] [Abstract][Full Text] [Related]
8. Navigating the complexities of drug development for inflammatory bowel disease. Honap S; Jairath V; Danese S; Peyrin-Biroulet L Nat Rev Drug Discov; 2024 Jul; 23(7):546-562. PubMed ID: 38778181 [TBL] [Abstract][Full Text] [Related]
9. Single cell RNA-sequencing profiling to improve the translation between human IBD and Karmele EP; Moldoveanu AL; Kaymak I; Jugder BE; Ursin RL; Bednar KJ; Corridoni D; Ort T Front Immunol; 2023; 14():1291990. PubMed ID: 38179052 [TBL] [Abstract][Full Text] [Related]
10. A Review of Available Medical Therapies to Treat Moderate-to-Severe Inflammatory Bowel Disease. Chang S; Murphy M; Malter L Am J Gastroenterol; 2024 Jan; 119(1):55-80. PubMed ID: 37615291 [TBL] [Abstract][Full Text] [Related]
11. Research advancements and perspectives of inflammatory bowel disease: A comprehensive review. Bai J; Wang Y; Li F; Wu Y; Chen J; Li M; Wang X; Lv B Sci Prog; 2024; 107(2):368504241253709. PubMed ID: 38778725 [TBL] [Abstract][Full Text] [Related]
12. Advanced Therapies for Inflammatory Bowel Disease: Navigating Payor and Financial Challenges. Whitmire N; Schlueter M; Kirkpatrick M Curr Gastroenterol Rep; 2024 Mar; 26(3):68-76. PubMed ID: 38243152 [TBL] [Abstract][Full Text] [Related]
13. Current Strategies and Potential Prospects of Nanomedicine-Mediated Therapy in Inflammatory Bowel Disease. Chen F; Liu Q; Xiong Y; Xu L Int J Nanomedicine; 2021; 16():4225-4237. PubMed ID: 34188471 [TBL] [Abstract][Full Text] [Related]
14. 5'AMP-activated protein kinase: an emerging target of phytochemicals to treat chronic inflammatory diseases. Abdul Khaliq H; Alhouayek M; Quetin-Leclercq J; Muccioli GG Crit Rev Food Sci Nutr; 2024; 64(14):4763-4788. PubMed ID: 36450301 [TBL] [Abstract][Full Text] [Related]
15. [Research advances on B-cell activating factor and its targeted agents in inflammatory bowel disease]. Li L; Liu HY; Wang LJ Zhongguo Dang Dai Er Ke Za Zhi; 2024 Mar; 26(3):315-320. PubMed ID: 38557386 [TBL] [Abstract][Full Text] [Related]
16. Immunomodulatory Effect of Phytoactive Compounds on Human Health: A Narrative Review Integrated with Bioinformatics Approach. Choudhary S; Khan S; Rustagi S; Rajpal VR; Khan NS; Kumar N; Thomas G; Pandey A; Hamurcu M; Gezgin S; Zargar SM; Khan MK Curr Top Med Chem; 2024; 24(12):1075-1100. PubMed ID: 38551050 [TBL] [Abstract][Full Text] [Related]
17. A systematic review of nano formulation of natural products for the treatment of inflammatory bowel disease: drug delivery and pharmacological targets. Taghipour YD; Bahramsoltani R; Marques AM; Naseri R; Rahimi R; Haratipour P; Iranpanah A; Panah AI; Farzaei MH; Abdollahi M Daru; 2018 Dec; 26(2):229-239. PubMed ID: 30382546 [TBL] [Abstract][Full Text] [Related]
18. Exploring Novel Herbal Compounds and Formulations for Inflammatory Bowel Disease (IBD) Management. Dubey RK; Shukla S Zhongguo Ying Yong Sheng Li Xue Za Zhi; 2023 Dec; 39():e20230003. PubMed ID: 38716509 [TBL] [Abstract][Full Text] [Related]
19. Recent developments and new directions in the use of natural products for the treatment of inflammatory bowel disease. Feng Y; Pan M; Li R; He W; Chen Y; Xu S; Chen H; Xu H; Lin Y Phytomedicine; 2024 Sep; 132():155812. PubMed ID: 38905845 [TBL] [Abstract][Full Text] [Related]
20. Current Controversies in Crohn's Disease: A Roundtable Discussion of the BRIDGe Group. Sparrow MP; Irving PM; Baidoo L; Bressler B; Cheifetz AS; Devlin SM; Harrell LE; Jones J; Kozuch PL; Melmed GY; Velayos FS; Siegel CA Gastroenterol Hepatol (N Y); 2008 Oct; 4(10):713-20. PubMed ID: 21960891 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]